Clinical Trials Browser

Resectable Pancreatic Cancer

Cholangiocarcinoma

Bile Duct Neoplasms, Cholangiocarcinoma

Neoplasm Metastasis, Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Liver Neoplasms

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease, Recurrence

Pancreatic Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse

Cholangiocarcinoma

Phase 2 Study

Borderline Resectable Pancreatic Adenocarcinoma

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis

Triple Negative Breast Neoplasms

Pancreatic Cystic Neoplasm

Infiltrating Bladder Urothelial Carcinoma

Nasopharyngeal Carcinoma

Biliary Tract Neoplasms

Neoplasm Metastasis

Pancreatic Adenocarcinoma

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Lymphoma, Large B-Cell, Diffuse

Advanced Biliary Tract Carcinoma

Mycosis Fungoides, Sezary Syndrome

Urinary Bladder Neoplasms

Lymphoma, Large B-Cell, Diffuse

Hodgkin Disease

Breast Neoplasms

Uterine Cervical Neoplasms

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Hodgkin Disease

Pancreatic Neoplasms

Rhabdoid Tumor

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Lung Diseases, Interstitial

Advanced Squamous Non-Small Cell Lung Cancer

Advanced Biliary Tract Carcinoma

Clinical Trials

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

ToPCourT

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

ORIGIN2

Study of Lacutamab in Peripheral T-cell Lymphoma

AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

LIGHT

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

SWITCH

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

INCA

A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

IMMUNOLIFE2

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

TACTIC

Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome

Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

GEMCOL

TRIFECTA

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

HOVON164HL

PANCREAS

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Intravesical Gem/Doce in Patients With NMIBC

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

CECYDE

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer